The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 20, 2026

Filed:

Dec. 04, 2020
Applicant:

Cis Biopharma Ag, Bubendorf, CH;

Inventors:

Christian Geraths, Rheinfelden, DE;

Rolf Schafer, Arisdorf, CH;

Assignee:

CIS Biopharma AG, Bubendorf, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 47/44 (2006.01); A01N 25/02 (2006.01); A01N 25/30 (2006.01); A01N 33/12 (2006.01); A01N 43/16 (2006.01); A01N 43/40 (2006.01); A01P 1/00 (2006.01); A61L 12/14 (2006.01);
U.S. Cl.
CPC ...
A01N 47/44 (2013.01); A01N 25/02 (2013.01); A01N 25/30 (2013.01); A01N 33/12 (2013.01); A01N 43/16 (2013.01); A01N 43/40 (2013.01); A01P 1/00 (2021.08); A61L 12/142 (2013.01); A61L 12/145 (2013.01);
Abstract

The present invention relates to ophthalmic formulations wherein a synergistic combination of three different classes of disinfectants (a multimeric biguanide compound, a quaternary ammonium compound and an antifungal/anti-acanthamoeba compound, in particular a combination of polyhexamethylene biguanide, Polyquaternium-1 and myristamidopropyl dimethylamine) enables the use of high concentrations of hyaluronate for providing better comfort and support of corneal health without compromising antimicrobial efficacy. The novel ophthalmic formulations support the use of more than 7.5 times higher concentrations of hyaluronate than are present in currently marketed multi-purpose disinfection solutions.


Find Patent Forward Citations

Loading…